Top 4 Stocks with Potential 20-40% Returns in 2026: Max Healthcare, Amber Enterprises, and More
Investors looking to capitalize on the robust market trends in 2026 have a few promising options, according to top brokerage firms. Goldman Sachs, Motilal Oswal, Elara Capital, and Citi have highlighted four stocks with strong business fundamentals and favorable sector tailwinds, offering potential returns of 20-40% over the next year.
Max Healthcare Institute Ltd is one of the standout recommendations, with Goldman Sachs maintaining a Buy rating and setting a target price of Rs 1,325. This represents a 26% upside from the current market price of Rs 1,048. The brokerage firm cites the company's solid financial health and strategic growth initiatives as key drivers of its positive outlook.
Aditya Birla Real Estate, another strong contender, has received a Buy recommendation from Motilal Oswal. The target price of Rs 2,275 implies a 32% potential upside from the current level of Rs 1,718. Motilal Oswal highlights the company's robust project pipeline and strong market position in the real estate sector as factors supporting its growth trajectory.
Amber Enterprises Ltd has also caught the attention of Elara Capital, which has maintained a Buy recommendation with a target price of Rs 8,460. This suggests a 28% upside from the last traded price of Rs 6,585. Elara Capital emphasizes the company's strong operational performance and market leadership in its sector as key reasons for its positive stance.
Lastly, Citi has reaffirmed its Buy rating on Divi’s Laboratories Ltd, assigning a target price of Rs 9,140. This translates into a potential upside of 43% from the current market price of Rs 6,380. Citi points to the company's strong research and development capabilities and its expanding global footprint as key factors contributing to its growth potential.
These recommendations are based on a comprehensive analysis of the companies' financial health, market positioning, and sector trends. Investors are advised to conduct their own research and consult with financial advisors before making any investment decisions.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
